IP Verse

Direct Compression Formulation And Process - EP3738585

The patent EP3738585 was granted to Novartis on Dec 14, 2022. The application was originally filed on Jan 17, 2005 under application number EP20177506A. The patent is currently recorded with a legal status of "Revoked".

EP3738585

NOVARTIS
Application Number
EP20177506A
Filing Date
Jan 17, 2005
Status
Revoked
May 23, 2025
Grant Date
Dec 14, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HERZOG PATENTANWALTSSep 11, 2023HERZOG PATENTANWALTSADMISSIBLE

Patent Citations (84) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS19740606042-
DESCRIPTIONUS20010788173-
DESCRIPTIONDE10256264
DESCRIPTIONDE19616486
DESCRIPTIONEP1245568
DESCRIPTIONEP1258476
DESCRIPTIONEP1258480
DESCRIPTIONUS2003087950
DESCRIPTIONUS2003096846
DESCRIPTIONUS2003096857
DESCRIPTIONUS2003216450
DESCRIPTIONUS2003225102
DESCRIPTIONUS6107317
DESCRIPTIONUS6110949
DESCRIPTIONUS6124305
DESCRIPTIONUS6166063
DESCRIPTIONUS6395767
DESCRIPTIONUS6482844
DESCRIPTIONWO0034241
DESCRIPTIONWO0134594
DESCRIPTIONWO0152825
DESCRIPTIONWO0155105
DESCRIPTIONWO0168603
DESCRIPTIONWO0172290
DESCRIPTIONWO0181337
DESCRIPTIONWO0197808
DESCRIPTIONWO0202560
DESCRIPTIONWO02051836
DESCRIPTIONWO02053548
DESCRIPTIONWO02062764
DESCRIPTIONWO02066627
DESCRIPTIONWO02067918
DESCRIPTIONWO02068420
DESCRIPTIONWO02076450
DESCRIPTIONWO02083109
DESCRIPTIONWO02083128
DESCRIPTIONWO0214271
DESCRIPTIONWO02308090
DESCRIPTIONWO0230890
DESCRIPTIONWO0238541
DESCRIPTIONWO03000180
DESCRIPTIONWO03000181
DESCRIPTIONWO03000250
DESCRIPTIONWO03002531
DESCRIPTIONWO03002553
DESCRIPTIONWO03002593
DESCRIPTIONWO03002942
DESCRIPTIONWO03003250
DESCRIPTIONWO03003727
DESCRIPTIONWO03004496
DESCRIPTIONWO03004498
DESCRIPTIONWO03024942
DESCRIPTIONWO03024965
DESCRIPTIONWO03035057
DESCRIPTIONWO03035067
DESCRIPTIONWO03037327
DESCRIPTIONWO03057200
DESCRIPTIONWO03068757
DESCRIPTIONWO03074500
DESCRIPTIONWO2004024184
DESCRIPTIONWO2004037169
DESCRIPTIONWO2004037181
DESCRIPTIONWO2004052850
DESCRIPTIONWO2004071454
DESCRIPTIONWO2004076433
DESCRIPTIONWO9310127
DESCRIPTIONWO9515309
DESCRIPTIONWO9529691
DESCRIPTIONWO9818763
DESCRIPTIONWO9819998
DESCRIPTIONWO9925719
DESCRIPTIONWO9938501
DESCRIPTIONWO9946272
DESCRIPTIONWO9961431
DESCRIPTIONWO9967278
DESCRIPTIONWO9967279
OPPOSITIONWO0004241
OPPOSITIONWO2005067976
OPPOSITIONWO2006021455
OTHEREP1715893
SEARCHJP2003327532
SEARCHUS2003078247
SEARCHUS6548481
SEARCHWO0034241

Non-Patent Literature (NPL) Citations (21) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- CHEMICAL ABSTRACTS, Database accession no. 251572-86-8-
DESCRIPTION- Diabetes, (19980000), vol. 47, pages 1253 - 1258-
DESCRIPTION- H.U. DEMUTH et al., J. Enzyme Inhibition, (19880000), vol. 2, pages 129 - 142-
DESCRIPTION- MONA PATEL, Expert Opinion Investig Drugs, (20030400), vol. 12, no. 4, pages 623 - 33-
DESCRIPTION- "SIZE REDUCTION", Handbook of Pharmaceutical Excipients, American Pharmaceutical Association, vol. 2-
DESCRIPTION- T. ALLEN, Pharmaceutical dosage forms, Chapman & Hall, (19970000), vol. 1, page 178-
DESCRIPTION- WALLACE T. ASHTON, Bioorganic & Medicinal Chemistry Letters, (20040000), vol. 14, pages 859 - 863-
EXAMINATION- John Edgar, "Declaration of Dr. Edgar John", (20200715), pages 1 - 3, URL: https://worldwide.espacenet.com/patent/search/family/034798877/publication/EP3023095A1?q=15199440.7, XP055810821-
EXAMINATION- Novartis Ag, "Proprietor's letter filed on 15-07-2020 in opposition proceedings EP15199440", (20200715), pages 1 - 7, URL: https://worldwide.espacenet.com/patent/search/family/034798877/publication/EP3023095A1?q=15199440.7, XP055810817-
EXAMINATION- Stefan Epskamp, "Interlocutory decision concerning EP15199440", (20210507), pages 1 - 10, URL: https://worldwide.espacenet.com/patent/search/family/034798877/publication/EP3023095A1?q=15199440.7, XP055810834-
OPPOSITION- Allen L V, Pe Luner, "Magnesium Stearate", Allen L V, Pe Luner, Arthur H Kibbe, Handbook of Pharmaceutical Excipients Third edition, Washington, D.C, American Pharmaceutical Association, (20000101), pages 305 - 308, ISBN 0-917330-96-X-
OPPOSITION- Gunsel William C, Charles J. Swartz, And Joseph L. Kanig, "Tablets", Gunsel William C, Charles J. Swartz, And Joseph L. Kanig, Leon Lachman, Herbert A. Lieberman, Theory and Practice of Industrial Pharmacy, Great Britain, Lea & Febiger, (19700101), pages 305 - 318, XP093131188-
OPPOSITION- Kibbe Arthur H, "Lactose", Kibbe Arthur H, Arthur H Kibbe, Handbook of Pharmaceutical Excipients Third edition, Washington, D.C, American Pharmaceutical Association, (20000101), pages 276 - 285, ISBN 0-917330-96-X, XP093131225-
OPPOSITION- Ralph F Shangraw, "Compressed Tablets by Direct Compression", Ralph F Shangraw, Lieberman H A , Lachman L , Schwartz J B, Pharmaceutical Dosage Forms Tablets Volume 1, US, Marcel Dekker, (19890101), pages 195 - 200, ISBN 978-0-8247-8044-9, XP093131206-
OPPOSITION- V Conway, M Mulski., "Sodium Starch Glycolate", V Conway, M Mulski., Arthur H Kibbe, Handbook of Pharmaceutical Excipients Third edition, Washington, D.C, American Pharmaceutical Association, (20000101), pages 501 - 504, ISBN 0-917330-96-X, XP093131233-
OPPOSITION- Wheatley T A, "Cellulose, Microcrystalline", Wheatley T A, Arthur H Kibbe, Handbook of Pharmaceutical Excipients Third edition, Washington, D.C, American Pharmaceutical Association, (20000101), pages 102 - 105, ISBN 0-917330-96-X, XP093131213-
OPPOSITION- Najib, N. ; Jalal, I., "Correlation between dissolution and disintegration rate constants for acetaminophen tablets", International Journal of Pharmaceutics, NL , (19880601), vol. 44, no. 1-3, doi:10.1016/0378-5173(88)90098-1, ISSN 0378-5173, pages 43 - 47, XP025554371
OPPOSITION- Patel, N.K. ; Upadhyay, A.H. ; Bergum, J.S. ; Reier, G.E., "An evaluation of microcrystalline cellulose and lactose excipients using an instrumented single station tablet press", International Journal of Pharmaceutics, NL , (19940926), vol. 110, no. 3, doi:10.1016/0378-5173(94)90242-9, ISSN 0378-5173, pages 203 - 210, XP023736129
OPPOSITION- Shikifumi Kitazawa, Ikuo Johno, Yoko Ito, Shigeo Teramura, Jutaro Okada, "Effects of hardness on the disintegration time and the dissolution rate of uncoated caffeine tablets", Journal of Pharmacy and Pharmacology, (19751001), vol. 27, no. 10, doi:10.1111/j.2042-7158.1975.tb09397.x, pages 765 - 770, XP093161696
OTHER- Desai Yogita, "A MECHANISTIC STUDY OF FLOW AND COMPRESSION BEHAVIOR OF PH VIOR OF PHARMACEUTICAL POWDERS CEUTICAL POWDERS", Open Access Dissertations. Paper 180., (20010101), pages viii-xxiv, 1 - 234, Open Access Dissertations. Paper 180., URL: https://digitalcommons.uri.edu/cgi/viewcontent.cgi?article=1198&context=oa_diss, (20220216), XP055892378-
OTHER- Patel N K; Upadhyay A H; Bergum J S; Reier G E, "An evaluation of microcrystalline cellulose and lactose excipients using an instrumented single station tablet press", INTERNATIONAL JOURNAL OF PHARMACEUTICS,, (19940926), vol. 110, pages 203 - 210, XP023736129

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents